Bhattacharya, Soumendu,De, Arnab,Narasimhan, Chakravarthy Nachu,Sharma, Manoj K.,Yang, Xiaoyu,Burlage, Rubi,Cheung, Jason K.
申请号：
AU2018263837
公开号：
AU2018263837A1
申请日:
2018.05.01
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The invention relates to stable formulations comprising antibodies or antigen binding fragments thereof that bind to cytotoxic T lymphocyte associated antigen 4 (CTLA4), optionally further containing an anti-human programmed death receptor 1 (PD-1) antibody or antigen binding fragment thereof. Also provided are methods of treating various cancers and chronic infections with the formulations of the invention.
